Advanced Biomed Inc Foreign Currency Transaction Gain Loss After Tax
Advanced Biomed Inc (ADVB) reported Foreign Currency Transaction Gain Loss After Tax of $31.01 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossAfterTax · last filed 2026-05-15
- Advanced Biomed Inc foreign currency transaction gain loss after tax for the quarter ending 2026-03-31 was $31.01K.
- Advanced Biomed Inc foreign currency transaction gain loss after tax for the quarter ending 2025-12-31 was $42.94K.
- Advanced Biomed Inc foreign currency transaction gain loss after tax for the quarter ending 2025-09-30 was $136.26K, a 45.95% decline year-over-year.
- Advanced Biomed Inc foreign currency transaction gain loss after tax for the quarter ending 2025-06-30 was $468.39K.
- Advanced Biomed Inc foreign currency transaction gain loss after tax for fiscal 2025 was -$233.81K.
- Advanced Biomed Inc foreign currency transaction gain loss after tax for fiscal 2024 was -$294.69K.
| Period end | Foreign Currency Transaction Gain Loss After Tax 3 month | Foreign Currency Transaction Gain Loss After Tax 3 month as first filed | Foreign Currency Transaction Gain Loss After Tax 6 month | Foreign Currency Transaction Gain Loss After Tax 9 month | Foreign Currency Transaction Gain Loss After Tax 9 month as first filed | Foreign Currency Transaction Gain Loss After Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31.01K 10-Q · filed 2026-05-15 | $73.95K derived: sum of 2 quarters · filed 2026-05-15 | $210.23K 10-Q · filed 2026-05-15 | $678.61K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | $42.94K 10-Q · filed 2026-02-13 | $179.21K 10-Q · filed 2026-02-13 | $647.60K derived: sum of 3 quarters · filed 2026-02-13 | $17.61K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-09-30 | $136.26K 10-Q · filed 2025-11-19 | $604.65K derived: sum of 2 quarters · filed 2025-11-19 | -$25.33K derived: sum of 3 quarters · filed 2026-05-15 | -$340.14K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | $468.39K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$161.59K derived: sum of 2 quarters · filed 2026-05-15 | -$476.40K derived: sum of 3 quarters · filed 2026-05-15 | -$233.81K 10-K · filed 2025-10-08 | ||
| 2025-03-31 | -$629.98K 10-Q · filed 2026-05-15 | -$621.98K 10-Q · filed 2025-05-15 | -$944.79K derived: sum of 2 quarters · filed 2026-05-15 | -$702.20K 10-Q · filed 2026-05-15 | -$735.37K 10-Q · filed 2025-05-15 | -$857.41K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$314.81K 10-Q · filed 2026-02-13 | -$72.34K 10-Q · filed 2026-02-13 | -$227.43K derived: sum of 3 quarters · filed 2026-02-13 | -$512.42K derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-09-30 | $252.10K 10-Q · filed 2025-11-19 | $87.38K derived: sum of 2 quarters · filed 2025-11-19 | -$197.61K derived: sum of 3 quarters · filed 2025-11-19 | |||
| 2024-06-30 | -$164.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$449.71K derived: sum of 2 quarters · filed 2025-10-08 | -$294.69K 10-K · filed 2025-10-08 | |||
| 2024-03-31 | -$284.99K 10-Q · filed 2025-05-15 | -$129.97K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |